Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

N Engl J Med. 2021 Aug 5;385(6):570-571. doi: 10.1056/NEJMc2107920. Epub 2021 Jun 2.

Authors

Affiliations

¹ Fred Hutchinson Cancer Research Center, Seattle, WA stakuva@hcrisa.org.za.
² Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
³ South African Medical Research Council, Cape Town, South Africa.
⁴ University of Cape Town, Cape Town, South Africa.
⁵ University of the Witwatersrand, Johannesburg, South Africa.
⁶ Right to Care, Johannesburg, South Africa.

No abstract available

Publication types

Letter

MeSH terms

Ad26COVS1
Aged
COVID-19 Vaccines / adverse effects*
Female
Humans
Middle Aged
Risk Factors
South Africa / epidemiology
Thromboembolism / epidemiology
Thromboembolism / etiology*

Substances

Ad26COVS1
COVID-19 Vaccines

Grants and funding